Skip to content

Exagen Inc. XGN PP&E (Gross)

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s pp&e (gross).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s PP&E (gross)?
Exagen Inc. (XGN) reported PP&E (gross) of $14.35M in Q1 2026.
How has Exagen Inc.'s PP&E (gross) changed year-over-year?
Exagen Inc.'s PP&E (gross) increased by 29.0% year-over-year, from $11.12M to $14.35M.
What is the long-term trend for Exagen Inc.'s PP&E (gross)?
Over 4 years (2021 to 2025), Exagen Inc.'s PP&E (gross) has grown at a 12.9% compound annual growth rate (CAGR), from $8.66M to $14.08M.
What does PP&E (gross) mean?
Total cost of all property, plant, and equipment before deducting accumulated depreciation — the gross investment in tangible assets.